| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.062 | 0.03 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.03 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.082 | 0.04 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.04 |